Both in a Mixed Lineage Leukemia (MLL) fusion protein induced AML mouse model (MLL-ENL) [27] and in a model using the retrovirally overexpressed oncogenes HOXA9 and MEIS1, the absence of β-catenin could prevent AML disease onset [28]. The gene discussed is KMT2A; the disease is acute myeloid leukemia.